Testing effectiveness (Phase 2)WithdrawnNCT05612633What this trial is testingZelavespib (PU-H71) in Subjects With AP-MPN or BP-MPNWho this might be right forAccelerated Phase MPNBlast Phase MPN Samus Therapeutics, Inc.
Early research (Phase 1)Ended earlyNCT05524857What this trial is testingCombination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)Who this might be right forMyeloproliferative Neoplasm Joseph Jurcic 2
Early research (Phase 1)Active Not RecruitingNCT04603001What this trial is testingStudy of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 MutationsWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more Eli Lilly and Company 260
Early research (Phase 1)Looking for participantsNCT04771572What this trial is testingStudy of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.Who this might be right forNon Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more Newave Pharmaceutical Inc 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05600894What this trial is testingVenetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative NeoplasmWho this might be right forChronic Myelomonocytic LeukemiaMyelodysplastic SyndromeMyelodysplastic Syndrome With Excess Blasts+2 more National Cancer Institute (NCI) 132
Not applicableLooking for participantsNCT07362225What this trial is testingMPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)Who this might be right forPolycythemia VeraET (Essential Thrombocythemia)Polycythemia Vera (PV)+52 more MPN Research Foundation 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06892223What this trial is testingAnti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical TransplantationWho this might be right forAcute Myeloid LeukaemiaMDS (Myelodysplastic Syndrome)MPN (Myeloproliferative Neoplasms) Istituto Clinico Humanitas 42